Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Maino

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
European Journal of Endocrinology|April 19, 2013
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patientsMaria Grazia Castagna, Gabriele Cevenini, Alexandra Theodoropoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|October 7, 2023
Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC PatientsFabio Maino, Monica Botte, Cristina Dalmiglio, et al.
European Journal of Endocrinology|September 8, 2022
No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccineTania Pilli, Cristina Dalmiglio, Gilda Dalmazio, et al.
International Journal of Molecular Sciences|March 29, 2023
Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid CancerSilvia Cantara, Cristina Dalmiglio, Carlotta Marzocchi, et al.
Diagnostics (Basel, Switzerland)|June 27, 2024
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid CancerLaura Valerio, Silvia Cantara, Elisa Mattii, et al.
Frontiers in Endocrinology|February 11, 2020
Nodular Thyroid Disease in the Era of Precision MedicineDario Tumino, Giorgio Grani, Marta Di Stefano, et al.
Frontiers in Endocrinology|March 21, 2022
Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer PatientsMarco Capezzone, Alfonso Sagnella, Silvia Cantara, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient PatientsMaria Grazia Castagna, Monica Dentice, Silvia Cantara, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2014
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection biasMaria Grazia Castagna, Valentina Belardini, Silvia Memmo, et al.
European Thyroid Journal|August 6, 2016
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid NodulesMario Rotondi, Maria Grazia Castagna, Carlo Cappelli, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
European Journal of Endocrinology|April 19, 2013
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patientsMaria Grazia Castagna, Gabriele Cevenini, Alexandra Theodoropoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|October 7, 2023
Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC PatientsFabio Maino, Monica Botte, Cristina Dalmiglio, et al.
European Journal of Endocrinology|September 8, 2022
No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccineTania Pilli, Cristina Dalmiglio, Gilda Dalmazio, et al.
International Journal of Molecular Sciences|March 29, 2023
Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid CancerSilvia Cantara, Cristina Dalmiglio, Carlotta Marzocchi, et al.
Diagnostics (Basel, Switzerland)|June 27, 2024
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid CancerLaura Valerio, Silvia Cantara, Elisa Mattii, et al.
Frontiers in Endocrinology|February 11, 2020
Nodular Thyroid Disease in the Era of Precision MedicineDario Tumino, Giorgio Grani, Marta Di Stefano, et al.
Frontiers in Endocrinology|March 21, 2022
Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer PatientsMarco Capezzone, Alfonso Sagnella, Silvia Cantara, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient PatientsMaria Grazia Castagna, Monica Dentice, Silvia Cantara, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2014
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection biasMaria Grazia Castagna, Valentina Belardini, Silvia Memmo, et al.
European Thyroid Journal|August 6, 2016
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid NodulesMario Rotondi, Maria Grazia Castagna, Carlo Cappelli, et al.
Pageof 3